Kazuki Aida

Mr. Kazuki Aida

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2024 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
KAKazuki Aida
Kazuki Aida
MMMitsuo Mita
Mitsuo Mita
RIReiko Ishii-Nozawa
Reiko Ishii-Nozawa
We previously reported that the sustained component of contraction induced by depolarizing stimulation by high K+ concentration in rat caudal arterial smooth muscle involves a Ca2+-induced Ca2+ sensitization mechanism whereby Ca2+ entry through voltage-gated Ca2+ channels activates proline-rich tyrosine kinase 2 (Pyk2), leading to activation of RhoA/Rho-associated kinase (ROCK). In the present study, we investigated a potential role for Pyk2-mediated RhoA/ROCK activation in contraction mediated by elevation of cytosolic free Ca2+ concentration ([Ca2+]i) induced by a Ca2+ ionophore, ionomycin, rather than by depolarizing stimulation. Ionomycin (60 µM) induced slow and sustained contraction of rat caudal arterial smooth muscle due to influx of Ca2+. Pre-treatment with a myosin light chain kinase (MLCK) inhibitor, ML-9 (30 µM), inhibited both the early phase (4 min) and the sustained phase (30 min) of ionomycin-induced contraction. On the other hand, a ROCK inhibitor, HA-1077 (3 µM), and Pyk2 inhibitors, sodium salicylate (10 mM) and PF-431396 (3 µM), suppressed only the sustained phase of ionomycin-induced contraction. A calmodulin (CaM) inhibitor, W-7 (150 µM), but not W-5 (150 µM), suppressed the early phase of contraction. Early or sustained increase of ionomycin-induced 20 kDa light chain of myosin (LC20) phosphorylation was inhibited by each inhibitor in a manner similar to the attenuation of contraction. These results indicate that the early phase of ionomycin-induced contraction is mediated by MLCK activation by [Ca2+]i elevation, whereas the sustained phase of ionomycin-induced contraction involves RhoA/ROCK activation and inhibition of myosin light chain phosphatase (MLCP) through CaM-independent Pyk2 activation by [Ca2+]i elevation.

1 April 2025 in Physiological Reports
Verified
Journal Article
Open access
KAKazuki Aida
Kazuki Aida
RIReiko Ishii‐Nozawa
Reiko Ishii‐Nozawa
MMMitsuo Mita
Mitsuo Mita
We previously reported that depolarization of the vascular smooth muscle plasma membrane activates the Ca2+‐dependent proline‐rich tyrosine kinase 2 (Pyk2) upstream of the RhoA/Rho‐associated kinase (ROCK) pathway, leading to phosphorylation of the myosin‐targeting subunit of myosin light chain phosphatase (MYPT1) and the 20 kDa light chain of myosin (LC20). However, the mechanism whereby Pyk2 activates RhoA remains unclear. It is conceivable that Rho guanine nucleotide exchange factors (RhoGEFs) may link activated Pyk2 to RhoA activation through phosphorylation and activation of RhoGEFs. In this study, we investigated the activation of RhoA and RhoGEFs in membrane depolarization‐induced contraction of rat caudal arterial smooth muscle. Rhosin, a RhoA inhibitor, concentration‐dependently inhibited both the phasic and tonic components of the 60 mM K+‐induced contraction, and the inhibition was particularly prominent in the tonic contraction. On the contrary, Y16, a RhoGEF inhibitor, had little inhibitory effect. Moreover, phosphorylation of MYPT1 was increased at Thr697 and Thr855 by 60 mM K+ stimulation for 15 min, and this increase in MYPT1 phosphorylation was inhibited in the presence of Rhosin, but not Y16. We conclude that Pyk2 activated in response to Ca2+ entry induced by depolarization may cause activation of Y16‐insensitive RhoGEFs and RhoA, resulting in sustained contraction.

Verified
Journal Article
Open access
PDF file
KAKazuki Aida
Kazuki Aida
MMMitsuo Mita
Mitsuo Mita
RIReiko Ishii-Nozawa
Reiko Ishii-Nozawa
It has previously been reported that the RhoA/Rho-associated kinase (ROCK) pathway is involved in depolarization-induced contraction triggered by high [K+] stimulation in rat caudal arterial smooth muscle. Furthermore, we reported that activation of the upstream Ca2+-dependent proline-rich tyrosine kinase 2 (Pyk2) leads to phosphorylation of myosin targeting subunit of myosin light chain phosphatase (MYPT1) and 20 kDa myosin light chain (LC20). These findings suggest that Rho guanine nucleotide exchange factors (RhoGEFs) or Rho GTPase-activating proteins (RhoGAPs) may mediate RhoA activation downstream of Pyk2, thereby contributing to depolarization-induced contraction. However, it remains unclear whether Pyk2 directly interacts with RhoGEFs or RhoGAPs. In this study, we investigated the interaction between Pyk2 and RhoGEFs or RhoGAPs during depolarization stimulation of rat caudal arterial smooth muscle. We examined the interaction between Pyk2 and RhoGEFs or RhoGAPs, which previously were identified in smooth muscle, specifically in rat caudal arterial smooth muscle, in response to 60 mM K+ stimulation by immunoprecipitation analysis. ArhGEF11, ArhGEF12, phosphorylated ArhGAP42 at Tyr792 (pTyr792-ArhGAP42) and phosphorylated ArhGAP42 at Tyr376 (pTyr376-ArhGAP42) co-immunoprecipitated with Pyk2. The co-immunoprecipitation of pTyr792-ArhGAP42, but not pTyr376-ArhGAP42, with Pyk2 was inhibited by a Pyk2 inhibitor, sodium salicylate. Furthermore, 60 mM K+ stimulation increased ArhGAP42 phosphorylation at Tyr792, which was also suppressed by sodium salicylate. These findings indicate that Pyk2-mediated phosphorylation of ArhGAP42 at Tyr792 may play a role in depolarization-induced contraction of rat caudal arterial smooth muscle.

1 September 2024
Verified
Preprint
Open access
KAKazuki Aida
Kazuki Aida
RIReiko Ishii-Nozawa
Reiko Ishii-Nozawa
MMMitsuo Mita
Mitsuo Mita
Not-yet-known not-yet-known not-yet-known unknown We previously reported that depolarization of the vascular smooth muscle plasma membrane activates the Ca 2+-dependent proline-rich tyrosine kinase 2 (Pyk2) upstream of the RhoA/Rho-associated kinase (ROCK) pathway leading to phosphorylation of MYPT1 (the myosin-targeting subunit of myosin light chain phosphatase) and the 20 kDa light chain of myosin (LC 20). The resulting sustained elevation of LC 20 phosphorylation then accounts for the tonic contractile response to membrane depolarization. However, the mechanism whereby Pyk2 activates RhoA remains unclear. It is conceivable that Rho guanine nucleotide exchange factors (RhoGEFs) may connect activated Pyk2 to RhoA activation via phosphorylation and activation of its RhoGEF activity. In this study, we investigated activation of RhoA and RhoGEFs in membrane depolarization-induced contraction of rat caudal arterial smooth muscle. Rhosin (10 - 30 µM), a RhoA inhibitor, concentration-dependently inhibited both the phasic and tonic components of the 60 mM K +-induced contractile response of arterial strips. This inhibitory effect of Rhosin was particularly prominent in the tonic component of contraction. On the other hand, Y16 ( 1 - 30 µM), a RhoGEF inhibitor, had little inhibitory effect on 60 mM K +-induced contraction. Moreover, phosphorylation of MYPT1 was increased at Thr697 and Thr855 by 60 mM K + stimulation for 15 min, compared with basal levels of MYPT1 phosphorylation, and this increase in MYPT1 phosphorylation was inhibited in the presence of Rhosin (30 µM), but not Y16 (30 µM). We conclude that Pyk2 activated in response to depolarization-induced Ca 2+ entry may cause activation of Y16-insensitive RhoGEFs and RhoA, resulting in sustained contraction.